Mordes John P, Liu Chao, Xu Shuhang
aDepartment of Medicine/Endocrinology, University of Massachusetts Medical School, Worcester, Massachusetts, USA bEndocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine, Jiangsu Branch of China Academy of Chinese Medical Science, Nanjing, China.
Curr Opin Endocrinol Diabetes Obes. 2015 Apr;22(2):91-7. doi: 10.1097/MED.0000000000000140.
PURPOSE OF REVIEW: Overweight and obesity together with their comorbidities have become increasingly prevalent worldwide. The need for well tolerated, effective interventions has become increasingly urgent. Here we review the pharmacology, benefits, and risks of Western and Chinese medications used for weight loss. RECENT FINDINGS: Lifestyle interventions for weight loss are efficacious, but have had limited long-term durability. Bariatric surgery is very effective for weight loss and reversal of type 2 diabetes mellitus (T2DM), but it is invasive and not consistently durable in all patients. Recent studies show that newer Western pharmaceuticals and some traditional Chinese medications may be effective for appropriate patients in need of weight loss. SUMMARY: New Western medications, notably lorcaserin, phentermine/topiramate, naltrexone/bupropion, and liraglutide, are more effective and possibly safer than older medications but have important side-effects. Chinese herbal medicines may have efficacy similar to that of older Western medications and with few side-effects, but data are limited. We suggest that for appropriate patients, in particular those with or at high risk for T2DM, the judicious use of these medications with lifestyle modification is justified. This may be particularly true in Asia where T2DM develops at a low BMI, though more data are needed to support this concept.
综述目的:超重和肥胖及其合并症在全球范围内日益普遍。对耐受性良好、有效的干预措施的需求变得越来越迫切。在此,我们综述用于减肥的西药和中药的药理作用、益处及风险。 最新发现:减肥的生活方式干预有效,但长期效果有限。减肥手术对减肥和2型糖尿病(T2DM)的逆转非常有效,但具有侵入性,且并非对所有患者都能持续有效。最近的研究表明,新型西药和一些传统中药可能对有减肥需求的合适患者有效。 总结:新型西药,尤其是氯卡色林、芬特明/托吡酯、纳曲酮/安非他酮和利拉鲁肽,比旧药更有效且可能更安全,但有重要的副作用。中药可能与旧西药疗效相似且副作用少,但数据有限。我们建议,对于合适的患者,特别是那些患有T2DM或有T2DM高风险的患者,合理使用这些药物并结合生活方式的改变是合理的。在亚洲,T2DM在较低的体重指数时就会发生,情况可能尤其如此,不过还需要更多数据来支持这一观点。
Curr Opin Endocrinol Diabetes Obes. 2015-4
Curr Obes Rep. 2021-3
Prog Cardiovasc Dis. 2018-6-8
Pharmacotherapy. 2013-5-26
Lancet. 2016-2-10
Metabolism. 2015-8-12
Diabetes Obes Metab. 2015-11
Curr Atheroscler Rep. 2016-7
Med Lett Drugs Ther. 2018-6-4
Curr Diab Rep. 2018-7-17
Curr Opin Behav Sci. 2016-6